Case report: Death in the emergency department: an unrecognized awake malignant hyperthermia-like reaction in a six-year-old.

A healthy 6-year-old boy developed lower extremity rigidity, trismus, and fever after playing in a splash pool. On arrival in the emergency department, he appeared to be seizing. An endotracheal tube was emergently placed using succinylcholine. Cardiac arrest followed. He could not be resuscitated. Postmortem genetic analysis found a novel RYR1 variant. Family testing revealed the same variant in his father who also had muscle contracture testing diagnostic for susceptibility to malignant hyperthermia and central core disease diagnosed histologically. Because there was no exposure to volatile anesthetics before the onset of symptoms, this is a case of "awake" malignant hyperthermia worsened by succinylcholine.

[1]  B. Brandom,et al.  Identical de novo Mutation in the Type 1 Ryanodine Receptor Gene Associated with Fatal, Stress-induced Malignant Hyperthermia in Two Unrelated Families , 2011, Anesthesiology.

[2]  G. Piluso,et al.  Novel missense mutations and unexpected multiple changes of RYR1 gene in 75 malignant hyperthermia families , 2011, Clinical genetics.

[3]  Gregory C. Allen,et al.  Clinical Presentation, Treatment, and Complications of Malignant Hyperthermia in North America from 1987 to 2006 , 2010, Anesthesia and analgesia.

[4]  A. E. Rossi,et al.  RyR1 S-Nitrosylation Underlies Environmental Heat Stroke and Sudden Death in Y522S RyR1 Knockin Mice , 2008, Cell.

[5]  R. Robinson,et al.  Mutations in RYR1 in malignant hyperthermia and central core disease , 2006, Human mutation.

[6]  Y. Hayashi,et al.  Malignant Hyperthermia in Japan: Mutation Screening of the Entire Ryanodine Receptor Type 1 Gene Coding Region by Direct Sequencing , 2006, Anesthesiology.

[7]  J. Lueck,et al.  Heat‐ and anesthesia‐induced malignant hyperthermia in an RyR1 knock‐in mouse , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  J. Payen,et al.  Presence of Two Different Genetic Traits in Malignant Hyperthermia Families: Implication for Genetic Analysis, Diagnosis, and Incidence of Malignant Hyperthermia Susceptibility , 2002, Anesthesiology.

[9]  T. Nelson.  Malignant hyperthermia: a pharmacogenetic disease of Ca++ regulating proteins. , 2002, Current molecular medicine.

[10]  V. R. Challa,et al.  Malignant hyperthermia and apparent heat stroke. , 2001, JAMA.

[11]  G. Gronert,et al.  Hyperkalemic cardiac arrest during anesthesia in infants and children with occult myopathies. , 1998, Clinical pediatrics.

[12]  K. Otsu,et al.  Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. , 1991, Science.

[13]  M. Phillips,et al.  Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia , 1990, Nature.

[14]  M. G. Larach.  Standardization of the Caffeine Halothane Muscle Contracture Test , 1989, Anesthesia and analgesia.

[15]  H. Ording.  Incidence of malignant hyperthermia in Denmark. , 1985, Anesthesia and analgesia.

[16]  G. Gronert,et al.  Human malignant hyperthermia: awake episodes and correction by dantrolene. , 1980, Anesthesia and analgesia.